IMPROVE bleeding risk score: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 1: Line 1:
#Redirect [[Venous thromboembolism prevention resident survival guide#IMPROVE Bleeding Risk Score]]
__NOTOC__
{{CMG}}; {{AE}} {{Rim}}
 
==Overview==
 
===IMPROVE Bleeding Risk Score===
===Calculation of the IMPROVE Bleeding Risk Score===
 
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''<ref name="pmid20453069">{{cite journal| author=Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK et al.| title=Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. | journal=Chest | year= 2011 | volume= 139 | issue= 1 | pages= 69-79 | pmid=20453069 | doi=10.1378/chest.09-3081 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20453069  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Active [[gastric ulcer|gastric]] or [[duodenal ulcer]] || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Prior [[bleeding]] within the last 3 months|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombocytopenia]] (<50x10<sup>9</sup>/L)||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age ≥ 85 years||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Liver failure]] ([[INR]]>1.5)||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Kidney failure|Severe kidney failure]] ([[GFR]]< 30 mL/min/m<sup>2</sup>)||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Admission to [[ICU]] or [[CCU]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Central venous catheter]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Rheumatic disease||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Active [[malignancy]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age: 40-84 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.5
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Male||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Kidney failure|Moderate kidney failure]] ([[GFR]]: 30-59 mL/min/m<sup>2</sup>)||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|}
 
 
===Interpretation of the IMPROVE Bleeding Risk Score===
 
The IMPROVE risk score for bleeding can be interpreted as such:<ref name="pmid20453069">{{cite journal| author=Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK et al.| title=Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. | journal=Chest | year= 2011 | volume= 139 | issue= 1 | pages= 69-79 | pmid=20453069 | doi=10.1378/chest.09-3081 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20453069  }} </ref>
* '''Score ≥7: Elevated risk of bleeding'''
* '''Score <7: Not elevated risk of bleeding'''
 
==References==
{{Reflist|2}}
 
 
[[Category:Cardiology]]
[[Category:Up-To-Date]]

Revision as of 00:22, 27 May 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

IMPROVE Bleeding Risk Score

Calculation of the IMPROVE Bleeding Risk Score

Variable Score[1]
Active gastric or duodenal ulcer 4.5
Prior bleeding within the last 3 months 4
Thrombocytopenia (<50x109/L) 4
Age ≥ 85 years 3.5
Liver failure (INR>1.5) 2.5
Severe kidney failure (GFR< 30 mL/min/m2) 2.5
Admission to ICU or CCU 2.5
Central venous catheter 2
Rheumatic disease 2
Active malignancy 2
Age: 40-84 years 1.5
Male 1
Moderate kidney failure (GFR: 30-59 mL/min/m2) 1


Interpretation of the IMPROVE Bleeding Risk Score

The IMPROVE risk score for bleeding can be interpreted as such:[1]

  • Score ≥7: Elevated risk of bleeding
  • Score <7: Not elevated risk of bleeding

References

  1. ↑ 1.0 1.1 Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK; et al. (2011). "Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators". Chest. 139 (1): 69–79. doi:10.1378/chest.09-3081. PMID 20453069.
Retrieved from "https://www.wikidoc.org/index.php?title=IMPROVE_bleeding_risk_score&oldid=973620"